General Range

FOR-ROXIN DP-500

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

FOR-ROXIN DP-500 Tablets by Fortune Labs contain Naproxen Sodium and Domperidone, a prescription combination intended for selected acute painful conditions accompanied by nausea or vomiting. Naproxen Sodium is a non-steroidal anti-inflammatory drug (NSAID) that reduces prostaglandin production, helping relieve pain and inflammation. Domperidone is a dopamine receptor antagonist with antiemetic properties that may help manage associated nausea. FOR-ROXIN DP-500 may be prescribed for selected acute migraine episodes when both ingredients are clinically necessary and the combination is approved. Available in blister strip packaging with a printed carton box, the medicine requires medical supervision, considering gastrointestinal health, kidney function, cardiovascular risks, potential QT prolongation, medication interactions and appropriate treatment duration.

CategoryGeneral Range

Min. Order100 boxes

Supplied byFortune Labs

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Naproxen Sodium & Domperidone Tablets
Packaging Type: Tablet Blister Strips with Printed Carton Box
Packaging Size: 10 × 10
Dosage Form: Tablet
Treatment: May be prescribed for selected migraine episodes accompanied by nausea when both ingredients are clinically appropriate.
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana

View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?